2025 International Congress » Drug-Induced Movement Disorders

Meeting: 2025 International Congress

A Novel Dopaminergic Modulator (NDM-101) as an Adjunct to Levodopa: Enhancing Motor Control Without Worsening Dyskinesia in Parkinson’s Disease

F. Al-Zaidi (Almaty, Kazakhstan)

Amitriptyline-Induced Rabbit Syndrome: A Case of Refractory Oral Vertical Dyskinesia

A. Medhus, E. Krause (Austin, USA)

Bridging the Care Gap for Individuals with Drug-Induced Movement Disorders Using Telemedicine: A Randomized Pilot Study

E. Houston, A. Kennedy, T. Rabinowitz, G. Rose, J. Boyd (Burlington, USA)

Cerebellar Syndrome and Parkinsonism Associated with Acquired Hepatocerebral Degeneration with Unusual Findings on Neuroimaging.

R. Sanjinez, J. Bestoso (Buenos Aires, Argentina)

Drug-Induced Movement Disorders in Elderly Patients with Dementia: A Case Study of Acute Dystonia Following Third-Generation Antipsychotic Use

A. Katok, D. Khasanova, I. Khasanov (Kazan, Russian Federation)

Exploring the Neuroprotective Potential of Raloxifene and Fulvestrant Against Haloperidol Induced Parkinson Disease; Insights into GPR30/PI3k/Akt/Nrf2 Signaling Pathways

S. Upadhayay, P. Kumar (BATHINDA, India)

Neuroprotective Effects of Co-Administered Hesperetin and Resveratrol Nanoparticles on Oxidative Stress and Neurobehavioral Deficits in Parkinson’s Disease

R. Rajput, S. Verma (Agra, India)

Neuroprotective Effects of Thymol in MPTP-Induced Parkinson’s Disease Model in Rats: Molecular Docking, Behavioral, Biochemical, and Histological Investigations

A. Kumar, V. Malhotra (Ahamdabad, India)

Neuroprotective Role of Diosgenin-Loaded Lipid Nanoparticles for Parkinson’s Disease: Pharmacokinetic and Pharmacodynamic Insights

R. Rajput, S. Verma (Agra, India)

Perinatal Dioxin Exposure and Dopaminergic Vulnerability in the Development of Motor Dysfunction Sequelae

N. Choudhury, S. Shugar, B. Carr (Gainesville, USA)

Physical, Mental, and Socioemotional Functional Improvement Following Valbenazine Treatment for TD: a Case Series

R. Bera, J. Nedzesky, I. Gandayuwana, D. Winkelman, D. Vanderhoef, M. Bron, M M. Perez-Rodriguez (San Diego, USA)

Scopolamine-induced Tardive Dyskinesia: A Case Report

H. Deville, M. Christie (Houston, USA)

« View all sessions from the 2025 International Congress.